Targeting Toll-Like Receptor Signaling Pathways for Design of Novel Immune Therapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1875-6220|5|1|29-38

ISSN： 1570-1638

Source： Current Drug Discovery Technologies, Vol.5, Iss.1, 2008-03, pp. : 29-38

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peptides Targeting Toll-Like Receptor Signalling Pathways for Novel Immune Therapeutics

By  

Current Pharmaceutical Design, Vol. 16, Iss. 9, 2010-03 ,pp. : 1063-1080

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Interactions in Interleukin and Toll-like Receptor Signaling Pathways

By  

Current Pharmaceutical Design, Vol. 20, Iss. 8, 2014-03 ,pp. : 1244-1258

Bentham Science Publishers

Access to resources Recommend Favorite

Toll-like receptor 9 agonists as cancer therapeutics

By Holtick Udo   Scheulen Max E   von Bergwelt-Baildon Michael S   Weihrauch Martin R  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 3, 2011-03 ,pp. : 361-372

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 6, 2015-08 ,pp. : 692-699

Bentham Science Publishers

Access to resources Recommend Favorite

Toll-like Receptors Signaling Pathways as a Potential Therapeutic Target in Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 24, Iss. 17, 2018-05 ,pp. : 1887-1898

Bentham Science Publishers

Access to resources Recommend Favorite